Severe sensory neuronopathy responsive to infliximab in primary Sjögren’s syndrome
- 8 October 2002
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 59 (7) , 1113-1114
- https://doi.org/10.1212/wnl.59.7.1113
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Infliximab in patients with primary Sjögren's syndrome: A pilot studyArthritis & Rheumatism, 2001
- Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in miceNeuroscience Letters, 2001
- Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathyBrain Research, 2001
- Axonal transport of TNF-α in painful neuropathy: distribution of ligand tracer and TNF receptorsJournal of Neuroimmunology, 2001
- Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia culturesJournal of Neuroimmunology, 1998
- Tumor Necrosis Factor‐α Regulates Nicotinic Responses in Mixed Cultures of Sympathetic Neurons and Nonneuronal CellsJournal of Neurochemistry, 1995